Smithbridge Asset Management’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $4.89M | Buy |
102,069
+3,079
| +3% | +$132K | 0.67% | 42 |
|
|
2026
Q1 | $3.64M | Sell |
98,990
-100,198
| -50% | -$4.75M | 0.54% | 49 |
|
|
2025
Q4 | $10.1M | Buy |
199,188
+104,709
| +111% | +$5.35M | 0.87% | 41 |
|
|
2025
Q3 | $5.24M | Buy |
94,479
+2,845
| +3% | +$167K | 0.76% | 47 |
|
|
2025
Q2 | $6.32M | Buy |
91,634
+3,103
| +4% | +$211K | 1.11% | 37 |
|
|
2025
Q1 | $6.15M | Buy |
+88,531
| New | +$7.31M | 1.14% | 34 |
|
|
2024
Q3 | $10.6M | Sell |
89,120
-3,207
| -3% | -$428K | 1.83% | 14 |
|
|
2024
Q2 | $13.2M | Sell |
92,327
-166
| -0.2% | -$22K | 2.74% | 6 |
|
|
2024
Q1 | $11.9M | Sell |
92,493
-3,128
| -3% | -$372K | 2.45% | 4 |
|
|
2023
Q4 | $9.89M | Sell |
95,621
-1,657
| -2% | -$164K | 2.25% | 5 |
|
|
2023
Q3 | $8.85M | Sell |
97,278
-2,908
| -3% | -$256K | 2.19% | 6 |
|
|
2023
Q2 | $8.11M | Sell |
100,186
-2,780
| -3% | -$227K | 1.9% | 6 |
|
|
2023
Q1 | $8.19M | Sell |
102,966
-4,434
| -4% | -$314K | 2.06% | 7 |
|
|
2022
Q4 | $7.27M | Sell |
107,400
-752
| -0.7% | -$44.1K | 1.93% | 12 |
|
|
2022
Q3 | $5.39M | Buy |
108,152
+974
| +0.9% | +$52.2K | 2.21% | 11 |
|
|
2022
Q2 | $5.97M | Sell |
107,178
-662
| -0.6% | -$36.7K | 2.31% | 9 |
|
|
2022
Q1 | $5.99M | Sell |
107,840
-610
| -0.6% | -$31.3K | 1.98% | 15 |
|
|
2021
Q4 | $6.07M | Sell |
108,450
-4,848
| -4% | -$263K | 1.85% | 20 |
|
|
2021
Q3 | $5.44M | Sell |
113,298
-4,054
| -3% | -$196K | 1.8% | 20 |
|
|
2021
Q2 | $4.92M | Buy |
117,352
+1,064
| +0.9% | +$41.2K | 1.6% | 24 |
|
|
2021
Q1 | $3.92M | Buy |
116,288
+2,140
| +2% | +$76.2K | 1.68% | 28 |
|
|
2020
Q4 | $3.99M | Sell |
114,148
-1,210
| -1% | -$41.8K | 1.84% | 24 |
|
|
2020
Q3 | $4M | Sell |
115,358
-340
| -0.3% | -$11.3K | 2.07% | 19 |
|
|
2020
Q2 | $3.79M | Sell |
115,698
-10,200
| -8% | -$325K | 2.11% | 17 |
|
|
2020
Q1 | $3.79M | Sell |
125,898
-13,290
| -10% | -$396K | 2.53% | 10 |
|
|
2019
Q4 | $4.03M | Sell |
139,188
-14,250
| -9% | -$395K | 2.08% | 16 |
|
|
2019
Q3 | $3.97M | Buy |
153,438
+1,590
| +1% | +$40.2K | 2.23% | 15 |
|
|
2019
Q2 | $3.88M | Sell |
151,848
-180
| -0.1% | -$4.45K | 2.24% | 13 |
|
|
2019
Q1 | $3.98M | Buy |
152,028
+2,150
| +1% | +$52.8K | 2.39% | 11 |
|
|
2018
Q4 | $3.45M | Buy |
149,878
+3,192
| +2% | +$70.9K | 2.42% | 12 |
|
|
2018
Q3 | $3.46M | Buy |
146,686
+1,040
| +0.7% | +$25.4K | 2.08% | 16 |
|
|
2018
Q2 | $3.36M | Buy |
145,646
+980
| +0.7% | +$23.3K | 2.15% | 17 |
|
|
2018
Q1 | $3.56M | Sell |
144,666
-2,468
| -2% | -$64.8K | 2.36% | 13 |
|
|
2017
Q4 | $3.95M | Buy |
147,134
+5,560
| +4% | +$141K | 2.49% | 8 |
|
|
2017
Q3 | $3.41M | Sell |
141,574
-4,540
| -3% | -$103K | 2.4% | 11 |
|
|
2017
Q2 | $3.13M | Buy |
146,114
+30,800
| +27% | +$622K | 2.58% | 14 |
|
|
2017
Q1 | $1.98M | Sell |
115,314
-3,560
| -3% | -$62K | 1.73% | 29 |
|
|
2016
Q4 | $2.13M | Buy |
118,874
+21,440
| +22% | +$389K | 1.88% | 26 |
|
|
2016
Q3 | $2.03M | Buy |
97,434
+26,626
| +38% | +$660K | 1.81% | 28 |
|
|
2016
Q2 | $1.9M | Sell |
70,808
-100
| -0.1% | -$2.74K | 1.77% | 28 |
|
|
2016
Q1 | $1.92M | Sell |
70,908
-4,800
| -6% | -$129K | 1.79% | 29 |
|
|
2015
Q4 | $2.2M | Sell |
75,708
-300
| -0.4% | -$8.3K | 2.02% | 25 |
|
|
2015
Q3 | $2.06M | Sell |
76,008
-3,200
| -4% | -$90.6K | 1.95% | 28 |
|
|
2015
Q2 | $2.17M | Sell |
79,208
-5,500
| -6% | -$155K | 1.82% | 31 |
|
|
2015
Q1 | $2.26M | Sell |
84,708
-100
| -0.1% | -$2.3K | 1.87% | 31 |
|
|
2014
Q4 | $1.79M | Sell |
84,808
-300
| -0.4% | -$6.7K | 1.47% | 34 |
|
|
2014
Q3 | $2.03M | Sell |
85,108
-202
| -0.2% | -$4.65K | 1.7% | 34 |
|
|
2014
Q2 | $1.97M | Sell |
85,310
-3,300
| -4% | -$72.9K | 1.66% | 33 |
|
|
2014
Q1 | $2.02M | Sell |
88,610
-5,230
| -6% | -$111K | 1.84% | 30 |
|
|
2013
Q4 | $1.73M | Sell |
93,840
-5,500
| -6% | -$95.9K | 1.59% | 32 |
|
|
2013
Q3 | $1.68M | Sell |
99,340
-500
| -0.5% | -$8.41K | 1.59% | 33 |
|
|
2013
Q2 | $1.55M | Buy |
+99,840
| New | +$1.66M | 1.56% | 31 |
|
Other funds holding NVO
F
Smithbridge Asset Management's NVO Position: Q2 2026 in Review
Smithbridge Asset Management increased its Novo Nordisk (NVO) stake by 3.1% in Q2 2026, buying an estimated $132K and bringing the position to 102,069 shares worth $4.89M. The position accounts for 0.67% of the portfolio, ranked #42.
Smithbridge Asset Management first reported a position in NVO in Q2 2013 and has held it in 52 quarters since. The position peaked at $13.2M in Q2 2024. 1,350 funds tracked by Wall St. Rank hold NVO as of Q2 2026.
- Smithbridge Asset Management held 102,069 shares of Novo Nordisk worth $4.89M as of Q2 2026.
- Smithbridge Asset Management bought 3,079 Novo Nordisk shares in Q2 2026, an estimated $132K.
- Novo Nordisk made up 0.67% of Smithbridge Asset Management's portfolio in Q2 2026, its #42 holding.
- Smithbridge Asset Management first reported a position in Novo Nordisk in Q2 2013 and has held it in 52 quarters since.
- Smithbridge Asset Management's Novo Nordisk position peaked at $13.2M in Q2 2024.
- 1,350 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.
Based on Smithbridge Asset Management's 13F filing for Q2 2026, filed 20 Jul 2026.